The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,198 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONSORED ADR | 023111206 | 9,778 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 1,501 | 720,000 | SH | SOLE | 720,000 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 492 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 8,006 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
AVENUE THERAPEUTICS INC | COM NEW | 05360L205 | 5,677 | 952,600 | SH | SOLE | 952,600 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 8,376 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HLDG | COM | G11196105 | 6,675 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADR | 09071M106 | 44 | 16,667 | SH | SOLE | 16,667 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 7,714 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 8,043 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 7,190 | 2,185,536 | SH | SOLE | 2,185,536 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 1,356 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 18,515 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 3,113 | 207,000 | SH | SOLE | 207,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 717 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
CYTOKINETICS | COM NEW | 23282W905 | 7,397 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 7,806 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
EDAP TMS SA | SPONSORED ADR | 268311107 | 1,347 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 10,991 | 305,550 | SH | SOLE | 305,550 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 14,080 | 1,365,000 | SH | SOLE | 1,365,000 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 7,363 | 1,165,000 | SH | SOLE | 1,165,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 5,547 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
FLEXION THERAPEUTICS INC | COM | 33938J106 | 1,439 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 034960Q19 | 2,334 | 1,655,000 | SH | SOLE | 1,655,000 | 0 | 0 | ||
FORTY SEVEN INC | COM | 34983P104 | 2,729 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
HARROW HEALTH | COM | 45323A201 | 13,319 | 2,370,000 | SH | SOLE | 2,370,000 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 1,270 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 3,950 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 2,836 | 995,000 | SH | SOLE | 995,000 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 2,622 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 8,436 | 2,775,000 | SH | SOLE | 2,775,000 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 9,111 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
PROTEON THERAPEUTICS INC | COM | 74371L109 | 14 | 54,000 | SH | SOLE | 54,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 6,426 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 4,063 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 3,354 | 141,800 | SH | SOLE | 141,800 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 1,931 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 4,789 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 14,286 | 4,070,000 | SH | SOLE | 4,070,000 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 1,171 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
SYNTHORX INC | COM | 87167A103 | 2,929 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 3,439 | 612,500 | SH | SOLE | 612,500 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 6,020 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
TURNING POINT THERAPEUTICS INC | COM | 90041T108 | 10,810 | 287,500 | SH | SOLE | 287,500 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 8,069 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
VERMILLION INC | COM NEW | 92407M206 | 661 | 1,265,000 | SH | SOLE | 1,265,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 7,391 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 4,216 | 170,000 | SH | SOLE | 170,000 | 0 | 0 |